Abstract
Recently, it has been suggested osteocytes control the activities of bone formation (osteoblasts) and resorption (osteoclast), indicating their important regulatory role in bone remodelling. However, to date, the role of osteocytes in controlling bone vascularisation remains unknown. Our aim was to investigate the interaction between endothelial cells and osteocytes and to explore the possible molecular mechanisms during angiogenesis. To model osteocyte/endothelial cell interactions, we co-cultured osteocyte cell line (MLOY4) with endothelial cell line (HUVECs). Co-cultures were performed in 1:1 mixture of osteocytes and endothelial cells or by using the conditioned media (CM) transfer method. Real-time cell migration of HUVECs was measured with the transwell migration assay and xCELLigence system. Expression levels of angiogenesis-related genes were measured by quantitative real-time polymerase chain reaction (qRT-PCR). The effect of vascular endothelial growth factor (VEGF) and mitogen-activated phosphorylated kinase (MAPK) signaling were monitored by western blotting using relevant antibodies and inhibitors. During the bone formation, it was noted that osteocyte dendritic processes were closely connected to the blood vessels. The CM generated from MLOY4 cells-activated proliferation, migration, tube-like structure formation, and upregulation of angiogenic genes in endothelial cells suggesting that secretory factor(s) from osteocytes could be responsible for angiogenesis. Furthermore, we identified that VEGF secreted from MLOY4-activated VEGFR2–MAPK–ERK-signaling pathways in HUVECs. Inhibiting VEGF and/or MAPK–ERK pathways abrogated osteocyte-mediated angiogenesis in HUVEC cells. Our data suggest an important role of osteocytes in regulating angiogenesis.
Similar content being viewed by others
References
Schipani E, Maes C, Carmeliet G, Semenza GL (2009) Regulation of osteogenesis-angiogenesis coupling by HIFs and VEGF. J Bone Miner Res 24:1347–1353. doi:10.1359/jbmr.090602
Clarkin CE, Emery RJ, Pitsillides AA, Wheeler-Jones CP (2008) Evaluation of VEGF-mediated signaling in primary human cells reveals a paracrine action for VEGF in osteoblast-mediated crosstalk to endothelial cells. J Cell Physiol 214:537–544. doi:10.1002/jcp.21234
Villars F, Guillotin B, Amedee T, Dutoya S, Bordenave L, Bareille R, Amedee J (2002) Effect of HUVEC on human osteoprogenitor cell differentiation needs heterotypic gap junction communication. Am J Physiol Cell Physiol 282:C775–C785. doi:10.1152/ajpcell.00310.2001
Street J, Bao M, deGuzman L, Bunting S, Peale FV Jr, Ferrara N, Steinmetz H, Hoeffel J, Cleland JL, Daugherty A, van Bruggen N, Redmond HP, Carano RA, Filvaroff EH (2002) Vascular endothelial growth factor stimulates bone repair by promoting angiogenesis and bone turnover. Proc Natl Acad Sci USA 99:9656–9661. doi:10.1073/pnas.152324099
Xue Y, Xing Z, Hellem S, Arvidson K, Mustafa K (2009) Endothelial cells influence the osteogenic potential of bone marrow stromal cells. Biomed Eng Online 8:34. doi:10.1186/1475-925X-8-34
Cackowski FC, Anderson JL, Patrene KD, Choksi RJ, Shapiro SD, Windle JJ, Blair HC, Roodman GD (2010) Osteoclasts are important for bone angiogenesis. Blood 115:140–149. doi:10.1182/blood-2009-08-237628
Engsig MT, Chen QJ, Vu TH, Pedersen AC, Therkidsen B, Lund LR, Henriksen K, Lenhard T, Foged NT, Werb Z, Delaisse JM (2000) Matrix metalloproteinase 9 and vascular endothelial growth factor are essential for osteoclast recruitment into developing long bones. J Cell Biol 151:879–889
Yang Q, McHugh KP, Patntirapong S, Gu X, Wunderlich L, Hauschka PV (2008) VEGF enhancement of osteoclast survival and bone resorption involves VEGF receptor-2 signaling and beta3-integrin. Matrix Biol 27:589–599. doi:10.1016/j.matbio.2008.06.005
Burger EH, Klein-Nulend J (1999) Mechanotransduction in bone: role of the lacuno-canalicular network. FASEB J 13:S101–S112
Klein-Nulend J, Nijweide PJ, Burger EH (2003) Osteocyte and bone structure. Curr Osteoporos Rep 1:5–10
Birmingham E, Niebur GL, McHugh PE, Shaw G, Barry FP, McNamara LM (2012) Osteogenic differentiation of mesenchymal stem cells is regulated by osteocyte and osteoblast cells in a simplified bone niche. Eur Cell Mater 23:13–27. doi:vol023a02
Cheung WY, Simmons CA, You L (2012) Osteocyte apoptosis regulates osteoclast precursor adhesion via osteocytic IL-6 secretion and endothelial ICAM-1 expression. Bone 50:104–110. doi:10.1016/j.bone.2011.09.052
Heino TJ, Hentunen TA, Vaananen HK (2004) Conditioned medium from osteocytes stimulates the proliferation of bone marrow mesenchymal stem cells and their differentiation into osteoblasts. Exp Cell Res 294:458–468. doi:10.1016/j.yexcr.2003.11.016
Yellowley CE, Li Z, Zhou Z, Jacobs CR, Donahue HJ (2000) Functional gap junctions between osteocytic and osteoblastic cells. J Bone Miner Res 15:209–217. doi:10.1359/jbmr.2000.15.2.209
Heino TJ, Hentunen TA, Vaananen HK (2002) Osteocytes inhibit osteoclastic bone resorption through transforming growth factor-beta: enhancement by estrogen. J Cell Biochem 85:185–197. doi:10.1002/jcb.10109
Zelzer E, Olsen BR (2005) Multiple roles of vascular endothelial growth factor (VEGF) in skeletal development, growth, and repair. Curr Top Dev Biol 65:169–187. doi:10.1016/S0070-2153(04)65006-X
Fukuda R, Hirota K, Fan F, Jung YD, Ellis LM, Semenza GL (2002) Insulin-like growth factor 1 induces hypoxia-inducible factor 1-mediated vascular endothelial growth factor expression, which is dependent on MAP kinase and phosphatidylinositol 3-kinase signaling in colon cancer cells. J Biol Chem 277:38205–38211. doi:10.1074/jbc.M203781200
Xu J, Liu X, Jiang Y, Chu L, Hao H, Liua Z, Verfaillie C, Zweier J, Gupta K, Liu Z (2008) MAPK/ERK signalling mediates VEGF-induced bone marrow stem cell differentiation into endothelial cell. J Cell Mol Med 12:2395–2406. doi:10.1111/j.1582-4934.2008.00266.x
Arnaoutova I, Kleinman HK (2010) In vitro angiogenesis: endothelial cell tube formation on gelled basement membrane extract. Nat Protoc 5:628–635. doi:10.1038/nprot.2010.6
Prasadam I, Mao X, Shi W, Crawford R, Xiao Y (2012) Combination of MEK–ERK inhibitor and hyaluronic acid has a synergistic effect on anti-hypertrophic and pro-chondrogenic activities in osteoarthritis treatment. J Mol Med (Berl). doi:10.1007/s00109-012-0953-5
Prasadam I, Friis T, Shi W, van Gennip S, Crawford R, Xiao Y (2010) Osteoarthritic cartilage chondrocytes alter subchondral bone osteoblast differentiation via MAPK signalling pathway involving ERK1/2. Bone 46:226–235. doi:10.1016/j.bone.2009.10.014
Prasadam I, Mao X, Wang Y, Shi W, Crawford R, Xiao Y (2012) Inhibition of p38 pathway leads to OA-like changes in a rat animal model. Rheumatology (Oxford) 51:813–823. doi:10.1093/rheumatology/ker360
Prasadam I, van Gennip S, Friis T, Shi W, Crawford R, Xiao Y (2010) ERK-1/2 and p38 in the regulation of hypertrophic changes of normal articular cartilage chondrocytes induced by osteoarthritic subchondral osteoblasts. Arthr Rheum 62:1349–1360. doi:10.1002/art.27397
Jaiprakash A, Prasadam I, Feng JQ, Liu Y, Crawford R, Xiao Y (2012) Phenotypic characterization of osteoarthritic osteocytes from the sclerotic zones: a possible pathological role in subchondral bone sclerosis. Int J Biol Sci 8:406–417. doi:10.7150/ijbs.4221
Afara I, Prasadam I, Crawford R, Xiao Y, Oloyede A (2012) Non-destructive evaluation of articular cartilage defects using near-infrared (NIR) spectroscopy in osteoarthritic rat models and its direct relation to Mankin score. Osteoarthr Cartil. doi:10.1016/j.joca.2012.07.007
Burra S, Nicolella DP, Jiang JX (2011) Dark horse in osteocyte biology: glycocalyx around the dendrites is critical for osteocyte mechanosensing. Commun Integr Biol 4:48–50. doi:10.4161/cib.4.1.13646
Bonewald LF (2005) Generation and function of osteocyte dendritic processes. J Musculoskelet Neuronal Interact 5:321–324
Weinstein RS, Nicholas RW, Manolagas SC (2000) Apoptosis of osteocytes in glucocorticoid-induced osteonecrosis of the hip. J Clin Endocrinol Metab 85:2907–2912
O’Brien CA, Jia D, Plotkin LI, Bellido T, Powers CC, Stewart SA, Manolagas SC, Weinstein RS (2004) Glucocorticoids act directly on osteoblasts and osteocytes to induce their apoptosis and reduce bone formation and strength. Endocrinology 145:1835–1841. doi:10.1210/en.2003-0990
Aguirre JI, Plotkin LI, Stewart SA, Weinstein RS, Parfitt AM, Manolagas SC, Bellido T (2006) Osteocyte apoptosis is induced by weightlessness in mice and precedes osteoclast recruitment and bone loss. J Bone Miner Res 21:605–615. doi:10.1359/jbmr.060107
Jilka RL, Weinstein RS, Parfitt AM, Manolagas SC (2007) Quantifying osteoblast and osteocyte apoptosis: challenges and rewards. J Bone Miner Res 22:1492–1501. doi:10.1359/jbmr.070518
Colopy SA, Benz-Dean J, Barrett JG, Sample SJ, Lu Y, Danova NA, Kalscheur VL, Vanderby R Jr, Markel MD, Muir P (2004) Response of the osteocyte syncytium adjacent to and distant from linear microcracks during adaptation to cyclic fatigue loading. Bone 35:881–891. doi:10.1016/j.bone.2004.05.024
Cai J, Jiang WG, Ahmed A, Boulton M (2006) Vascular endothelial growth factor-induced endothelial cell proliferation is regulated by interaction between VEGFR-2, SH-PTP1 and eNOS. Microvasc Res 71:20–31. doi:10.1016/j.mvr.2005.10.004
Shalaby F, Rossant J, Yamaguchi TP, Gertsenstein M, Wu XF, Breitman ML, Schuh AC (1995) Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature 376:62–66. doi:10.1038/376062a0
Lobov IB, Brooks PC, Lang RA (2002) Angiopoietin-2 displays VEGF-dependent modulation of capillary structure and endothelial cell survival in vivo. Proc Natl Acad Sci USA 99:11205–11210. doi:10.1073/pnas.172161899
Hangai M, Murata T, Miyawaki N, Spee C, Lim JI, He S, Hinton DR, Ryan SJ (2001) Angiopoietin-1 upregulation by vascular endothelial growth factor in human retinal pigment epithelial cells. Invest Ophthalmol Vis Sci 42:1617–1625
Ball SG, Shuttleworth CA, Kielty CM (2007) Vascular endothelial growth factor can signal through platelet-derived growth factor receptors. J Cell Biol 177:489–500. doi:10.1083/jcb.200608093
Pendu R, Terraube V, Christophe OD, Gahmberg CG, de Groot PG, Lenting PJ, Denis CV (2006) P-selectin glycoprotein ligand 1 and beta2-integrins cooperate in the adhesion of leukocytes to von Willebrand factor. Blood 108:3746–3752. doi:10.1182/blood-2006-03-010322
Somanath PR, Malinin NL, Byzova TV (2009) Cooperation between integrin alphavbeta3 and VEGFR2 in angiogenesis. Angiogenesis 12:177–185. doi:10.1007/s10456-009-9141-9
Starke RD, Ferraro F, Paschalaki KE, Dryden NH, McKinnon TA, Sutton RE, Payne EM, Haskard DO, Hughes AD, Cutler DF, Laffan MA, Randi AM (2011) Endothelial von Willebrand factor regulates angiogenesis. Blood 117:1071–1080. doi:10.1182/blood-2010-01-264507
Genersch E, Hayess K, Neuenfeld Y, Haller H (2000) Sustained ERK phosphorylation is necessary but not sufficient for MMP-9 regulation in endothelial cells: involvement of Ras-dependent and -independent pathways. J Cell Sci 113(Pt 23):4319–4330
Funahashi Y, Shawber CJ, Sharma A, Kanamaru E, Choi YK, Kitajewski J (2011) Notch modulates VEGF action in endothelial cells by inducing Matrix metalloprotease activity. Vasc Cell 3:2. doi:10.1186/2045-824X-3-2
Hashiramoto A, Sakai C, Yoshida K, Tsumiyama K, Miura Y, Shiozawa K, Nose M, Komai K, Shiozawa S (2007) Angiopoietin 1 directly induces destruction of the rheumatoid joint by cooperative, but independent, signaling via ERK/MAPK and phosphatidylinositol 3-kinase/Akt. Arthr Rheum 56:2170–2179. doi:10.1002/art.22727
Ge C, Xiao G, Jiang D, Franceschi RT (2007) Critical role of the extracellular signal-regulated kinase-MAPK pathway in osteoblast differentiation and skeletal development. J Cell Biol 176:709–718. doi:10.1083/jcb.200610046
Zhang W, Liu HT (2002) MAPK signal pathways in the regulation of cell proliferation in mammalian cells. Cell Res 12:9–18. doi:10.1038/sj.cr.7290105
Yashima R, Abe M, Tanaka K, Ueno H, Shitara K, Takenoshita S, Sato Y (2001) Heterogeneity of the signal transduction pathways for VEGF-induced MAPKs activation in human vascular endothelial cells. J Cell Physiol 188:201–210. doi:10.1002/jcp.1107
Acknowledgments
The authors would like to thank staff at Medical Engineering Research Facility (MERF) for assistance in the care of in vivo animals.
Conflict of interest
Authors declare there is no conflict of interest associated with this project.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Prasadam, I., Zhou, Y., Du, Z. et al. Osteocyte-induced angiogenesis via VEGF–MAPK-dependent pathways in endothelial cells. Mol Cell Biochem 386, 15–25 (2014). https://doi.org/10.1007/s11010-013-1840-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11010-013-1840-2